MARTHA PHILLIPS: Open Payments
NPI 1730578303 · DELHI, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$680 in 19 payments from 7 companies in 2025. Trend: 2023 $395 · 2024 $847 · 2025 $680
Food & beverage: $662Education: $18
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 7 | $269 |
| E.R. Squibb & Sons, L.L.C. | 6 | $208 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $83 |
| Neurocrine BioSciences, Inc. | 2 | $50 |
| ABBVIE INC. | 1 | $26 |
| Alkermes, Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
Products named: INVEGA SUSTENNA, COBENFY, JARDIANCE, INGREZZA, VRAYLAR, ARISTADA, UZEDY.
Industry payments across LA — which companies pay providers there.
